Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension

Documenti analoghi

• Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
  di: Bubb, Kristen J, et al.
  Pubblicazione: (2014)
• Engineering of a red-light–activated human cAMP/cGMP-specific phosphodiesterase
  di: Gasser, Carlos, et al.
  Pubblicazione: (2014)
• Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
  di: Pavlaki, Nikoleta, et al.
  Pubblicazione: (2018)
• Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation.
  di: Turko, I V, et al.
  Pubblicazione: (1998)
• Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.
  di: Meacci, E, et al.
  Pubblicazione: (1992)